NantHealth Inc. | Mutual Funds
Mutual Funds that own NantHealth Inc.
iShares Nasdaq Biotechnology ETF
1,245,870
1.13%
-16,296
0.03%
09/06/2018
Vanguard Extended Market Index Fund
561,730
0.51%
0
0%
07/31/2018
iShares Russell 2000 ETF
517,751
0.47%
-276
0%
09/06/2018
Fidelity Spartan Extended Market Index Fund
151,574
0.14%
0
0%
07/31/2018
iShares Russell 2000 Value ETF
137,839
0.13%
0
0%
09/06/2018
Infinity Q Diversified Alpha Fund
113,205
0.1%
0
0.15%
08/31/2017
iShares Russell 2000 Growth ETF
78,209
0.07%
0
0%
09/06/2018
Fidelity Nasdaq Composite Index
61,589
0.06%
0
0%
07/31/2018
Fidelity Spartan Total Market Index Fund
56,729
0.05%
0
0%
07/31/2018
iShares Micro Cap ETF
54,617
0.05%
0
0.01%
09/06/2018
| Address |
9920 Jefferson Boulevard
Culver City California 90232
United States
|
|
Employees
|
- |
| Website |
http://www.nanthealth.com |
| Updated |
07/08/2019 |
| NantHealth, Inc. ooperates as an evidence-based, personalized healthcare company, which provides treatment for critical diseases such as cancer. It is based on personalized healthcare approach that integrates novel diagnostics with large scale, biometric and phenotypic data to track patient outcomes and deliver precision medicine. The company was founded by Patrick Soon-Shiong in July 2010 and is headquartered in Culver City, CA. |
